Plastic surgery marketing agency for US practices — ABPS/ASPS board-certification-aware, HIPAA-safe, 50-state board-compliant
Ichelon Global is a plastic surgery marketing agency headquartered in Dallas, Texas, running consult acquisition and referral development for US ABPS and ASPS board-certified plastic surgeons across all 50 states. Plastic surgery is the highest-consideration cash-pay procedure category in US medicine — ticket sizes of $5,000 to $60,000, buyer research windows of six to eighteen months, and a compliance envelope that has tightened materially since the BBL post-2022 safety guidance. Every campaign is scoped inside HIPAA + TCPA + FTC + FDA + state medical board + ABPS/ASPS advertising-guidance envelope, with financing-partner integration (CareCredit, Alphaeon, PatientFi, Cherry) built into the funnel.
Backed by App\Support\NamedExperts::get(). --}}
- Ichelon Global is a Dallas-headquartered plastic surgery marketing agency serving US practices — solo ABPS-certified surgeons, multi-surgeon plastic surgery groups, and PE-backed cosmetic surgery platforms — across Texas, California, Florida, New York, Georgia, Arizona, Tennessee, Illinois, Washington and every other state where an ABPS/ASPS board-certified surgeon can advertise.
- Every engagement is scoped against HIPAA (OCR 2022/2024 tracking bulletin), TCPA (2024 FCC revocation updates), CAN-SPAM, ADA, FTC 16 CFR §255 Endorsement Guides, FDA 21 CFR §202.1, ABPS and ASPS advertising guidance, The Aesthetic Society standards, state medical board rules, and post-2022 BBL safety framing where relevant.
- Retainers are custom-scoped per practice, typically $2,500 to $8,000 per month. Consult CPQL runs $120 to $500 depending on procedure category, metro tier, and whether the campaign is scoped to fill first-consult slots or specifically to book operative cases.
- Delivery stack covers organic search, Google Ads, Meta Ads, GBP density, RealSelf, YouTube surgeon-authority (YODA), reputation cross-monitoring, financing partner (CareCredit, Alphaeon, PatientFi, Cherry) integration into consult and consult-to-book flow, and CRM attribution back to signed operative cases.
A marketing agency that treats plastic surgery as its own vertical — ABPS/ASPS credibility as the acquisition anchor
Plastic surgery is not aesthetic dermatology at a higher price point. It is a fundamentally different commercial motion. Ticket sizes run from $5,000 for a rhinoplasty deposit to $60,000 for a full body-lift-and-breast-augmentation combination case. Buyer research windows run six to eighteen months for elective cosmetic cases, longer for reconstructive. The clinical stakes are materially higher — a bad rhinoplasty is a decade of revision hell for the patient and a decade of medico-legal exposure for the surgeon. The regulatory envelope is materially tighter — ABPS and ASPS both maintain advertising guidance that goes further than state medical board rules alone, and The Aesthetic Society publishes its own overlay. And since 2022, BBL safety framing has become its own compliance category following the multi-society BBL safety advisories.
All of that changes the marketing job. A performance-marketing agency that made a nice CPQL number on a dermatology account cannot just translate the playbook to plastic surgery and expect it to hold. Plastic surgery patients are researching the surgeon far more than the practice, they are cross-checking board certification against fake claims that have proliferated in the category, they want the surgeon's revision rate, their volume, their hospital privileges. They are financing the case with a specific partner (CareCredit, Alphaeon, PatientFi, Cherry) rather than paying cash upfront in most price bands, and the marketing has to intercept that financing decision inside the consult-to-book flow. And they are triangulating trust across RealSelf reviewer profiles, Reddit surgery subreddits, YouTube surgeon channels, and Instagram case galleries. Getting one of those wrong loses the case even if the paid-media click was cheaper than a competitor's.
Ichelon Global was built to sit exactly at that intersection — plastic surgery consult acquisition inside a board-certification-anchored compliance envelope, with financing partner integration built into the funnel, not bolted on afterward. Our Dallas HQ at 3714 Matador Dr sits in the Central time zone that most US plastic surgery practices run leadership calls on, and Santosh Reddy leads our US practice from that address. Texas concentrates one of the highest densities of ABPS-certified plastic surgeons in the country, particularly across DFW and Houston, and DFW anchors an outsized share of the country's aesthetic-surgery cash-pay revenue.
But the Dallas address is a delivery pod anchor, not a client-geography limit. We run active engagements across Texas, California, Florida, New York, Georgia, Arizona, Tennessee, Illinois and Washington, and we scope net-new engagements in any state where an ABPS/ASPS-certified plastic surgeon can advertise. Multi-state cosmetic surgery groups and PE-backed platforms get a single national delivery pod with per-state creative review, per-state paid-media benchmarks, per-surgeon content publishing, and consolidated financing partner integration across every location.
ABPS, ASPS and The Aesthetic Society — the advertising overlay every plastic surgery campaign runs inside
Above state medical board rules and the federal envelope sits an additional advertising overlay specific to plastic surgery: the American Board of Plastic Surgery (ABPS) board-certification standards, the American Society of Plastic Surgeons (ASPS) code of ethics and advertising guidance, and The Aesthetic Society (formerly ASAPS) standards. Between them, these three bodies define what "board certified plastic surgeon" can mean in advertising, how before/after images can be used, and how procedure claims must be substantiated. A national plastic surgery marketing plan that treats these as suggestions rather than governing rules will trip an ethics complaint eventually — and the reputational damage of a public complaint outlasts the temporary CPQL win from crossing the line.
ABPS (American Board of Plastic Surgery)
The board certification standard for plastic surgery — the only board that is a member of the American Board of Medical Specialties for the plastic surgery specialty. Only ABPS diplomates can accurately advertise as "board certified in plastic surgery" in US medicine. Every campaign asset — website copy, GBP posts, ads, YouTube titles — is scoped against this standard, and we systematically remove language that implies board certification the surgeon does not actually hold.
ASPS (American Society of Plastic Surgeons)
The professional society for ABPS-certified plastic surgeons. ASPS maintains a Code of Ethics that includes advertising standards on truthful claims, before/after imagery, and testimonial usage. ASPS members who violate these standards face society-level discipline in addition to state medical board action. Campaign creative is scoped against the ASPS advertising standards baseline.
The Aesthetic Society (formerly ASAPS)
Specialty society for ABPS-certified plastic surgeons who focus on aesthetic (as opposed to reconstructive) practice. Publishes advertising guidelines that emphasise realistic outcome depiction, disclosure of surgical risk, and honest before/after imagery. Adds an overlay on top of ASPS baseline for aesthetic-focused practices.
BBL safety framing (post-2022 multi-society guidance)
Multiple plastic surgery societies published joint safety guidance on Brazilian Butt Lift procedures following mortality events tied to fat-injection technique. Any BBL creative post-2022 has to reflect that safety framing — subfascial technique, ultrasound guidance, appropriate patient selection. Marketing that ignores post-2022 BBL safety language is a discovery liability. We scope every BBL creative and content piece against the current joint guidance.
Financing partner integration — where a plastic surgery consult actually converts to a booked case
Most US plastic surgery cases in the $5,000 to $30,000 band are financed rather than paid in full at booking. The financing decision is made inside the consult-to-book window, and the practice that integrates financing into the consult flow rather than treating it as a payment-desk afterthought converts materially more consults into signed cases. Ichelon Global builds financing partner integration into every plastic surgery engagement.
CareCredit
The largest healthcare financing partner in the US and the most-recognised name in plastic surgery financing. Pre-consult financing eligibility check, in-consult application handoff, post-consult financing follow-up drip — all built into the acquisition engagement. CareCredit-friendly language pre-qualified in every campaign creative.
Alphaeon Credit
Specialty aesthetic financing partner with a strong footprint in plastic surgery and aesthetic dermatology. Higher approval rates than general medical financing in some buyer segments. Integrated into consult booking flow and post-consult financing options page.
PatientFi
Elective procedure financing partner focused on plastic surgery, dental and fertility. Frequently competitive on longer-term payment schedules for higher-ticket procedures ($15K+). Pre-consult application intercepts and post-consult financing offer landing pages both scoped into the funnel.
Cherry
Point-of-sale patient financing with rapid application flow and increasing adoption across plastic surgery practices. Instant-approval workflows built into consult check-in and post-consult follow-up SMS.
Financing partner integration is one of the highest-ROI additions to a plastic surgery marketing engagement. Practices that treat financing as a separate ops workflow leave 15 to 30 percent of consult-to-book conversion on the table compared to practices that integrate financing pre-consult and inside the consult itself. We build the pre-consult financing check landing pages, the SMS reminder sequences that surface financing options, and the post-consult financing follow-up drips — all scoped for FTC truth-in-lending compliance and TCPA consent rules.
The US plastic surgery market — the numbers that shape the strategy
A national plastic surgery marketing plan has to start from the actual size and shape of the US market. Not from what worked in one metro. Not from what a competitor said in a case study. From the underlying practice-count, procedure-volume, and demand data.
Board-certified plastic surgeons number roughly 7,000 to 8,000 across the US per ABPS certification records, and full plastic surgery practices concentrate heavily in specific metros rather than being evenly distributed. Aesthetic-focused plastic surgery is a subset of that count that sits inside the wider $9.46 billion US aesthetic market. Body-contouring procedures (BBL, tummy tuck, mommy makeover, post-GLP-1 body lift), breast procedures (augmentation, lift, reduction, revision), face procedures (rhinoplasty, facelift, blepharoplasty, neck lift, deep-plane facelift) and gender-affirmation surgery are the primary revenue drivers, in that rough order across most practices.
Five state-level realities shape a US plastic surgery marketing plan today:
- Florida is the #1 US market for plastic surgery volume by cash-pay case count. Miami is the single largest plastic surgery destination market in the country, driven by both local demand and inbound aesthetic tourism from the Northeast, the Caribbean and Latin America. Florida Statute 458.351 governs physician advertising, and the Miami plastic surgery buyer is arguably the most researched in the country before booking.
- California is the second-largest US plastic surgery market with the highest average ticket. Los Angeles (Beverly Hills specifically), San Francisco, San Diego and Orange County anchor the state's plastic surgery economy. California's Bus & Prof Code §17500, Medical Board §2261, and Medical Corporation entity rules add compliance layers most other states do not carry. Beverly Hills plastic surgery consult tickets sit at the top of the country.
- Texas is the third-largest US plastic surgery market and one of the highest-growth. Dallas-Fort Worth and Houston anchor state plastic surgery density, with strong growth also in Austin and San Antonio. Texas Medical Board Rule 165.5 governs testimonials and before/after photography, and the DFW cosmetic surgery corridor concentrates high-volume ABPS-certified surgeons.
- New York plastic surgery concentrates around Manhattan. Manhattan plastic surgery ticket is at or above Beverly Hills on face and breast categories. New York Education Law §6530 governs physician advertising and is enforced tightly on superlative claim substantiation. Long Island, Westchester and NJ suburb catchments extend the Manhattan pull.
- Scottsdale, Atlanta and Nashville are the rising cohort. These three metros grew plastic surgery density fastest between 2020 and 2025. Post-GLP-1 body-lift demand and mommy-makeover volumes are both concentrated in these metros' age and demographic mix.
The top-demand US plastic surgery markets by paid-media auction pressure and organic search competitiveness are Miami, Beverly Hills, Manhattan, Dallas, Houston and Scottsdale. A national plastic surgery plan that budgets to a US-wide average CPC will overspend in mid-tier metros and underspend in the top six — which is where a specialist agency earns its fee by moving media budget to metros where a $350 CPC still returns a positive signed-case LTV, and away from metros where a lower-nominal CPC still fails to convert.
State medical board rules on plastic surgery advertising — the 50-state compliance matrix
Every US plastic surgeon advertises under three layers: the ABPS/ASPS/Aesthetic Society overlay described above, the federal envelope described below, and the individual state medical board that issued the surgeon's licence. Below is the condensed 50-state matrix Ichelon Global works from. This is the operating map, not a legal opinion — every practice's specific facts should be reviewed by its own healthcare counsel before creative deployment.
| State | Governing rule / statute | Key stance on plastic surgery advertising |
|---|---|---|
| Texas | TMB Rule 165.5 & 165.1 | Written patient consent required for every testimonial and before/after image; no false, deceptive or misleading claims; superiority claims require verifiable methodology; false board certification claims are prosecuted. |
| Florida | Florida Statute 458.351 | Ban on deceptive advertising, mandatory disclosure of physician's medical qualifications, licensed name and board certification required, before/after imagery must reflect typical results, BBL safety framing scrutinised. |
| California | CA Bus & Prof Code §17500 + Medical Board §2261 | Broadest truthful-advertising rule in the US; no misleading testimonials; strict on "board certified in plastic surgery" claims (must be ABPS or ABMS-equivalent); disclosure of non-typical before/after results. |
| New York | NY Education Law §6530 | Professional misconduct rules cover any false, fraudulent or deceptive advertising by a licensed physician; strong on superiority claim substantiation; scrutiny on board-certification language. |
| Georgia | GA Code §43-34-8 | Requires truthful, current-standard-of-care representation of results; no comparative superiority without objective basis; surgeon credentials disclosure required. |
| Arizona | AZ Rev Stat §32-1454 | Testimonials must be honest and current; before/after must not misrepresent typical outcome; strict on board-certification claims; Scottsdale market receives frequent enforcement attention. |
| Tennessee | TN Code §63-6-214 | Deceptive advertising is unprofessional conduct; testimonials without disclosure of compensation prohibited; Nashville plastic surgery practices watched on before/after and financing claims. |
| Illinois | IL Medical Practice Act §225 ILCS 60 | Strict on advertising outcomes as guarantees; before/after images require typical-results disclaimer where applicable; scrutiny on board-certification and hospital-privilege claims. |
| Washington | WA Medical Practice Act RCW 18.71 | Broad prohibition on false, fraudulent, misleading or deceptive statements in advertising; strict on non-ABPS surgeons using "plastic surgery" language. |
| Pennsylvania | 49 Pa Code §16.61 | Bans deceptive statements, requires substantiation of claims, physician-name and credentials attribution required, before/after imagery must be current and reflect typical results. |
| All other states | State-specific board rules apply | Every remaining state has a materially similar deceptive-advertising prohibition. Ichelon Global scopes creative against the actual current rule and interpretive guidance of the state your surgeon is licensed in, layered under the ABPS/ASPS/Aesthetic Society overlay. |
For multi-state plastic surgery groups, we maintain a per-state creative review checklist that runs against every campaign asset — website copy, paid creative, GBP posts, Instagram case galleries, YouTube titles, review-response templates, financing partner co-marketing pages — before it goes live in that state. A single national creative that reads clean in Texas can trigger a Florida deceptive-advertising complaint if the BBL safety language is not appropriately hedged for the Florida Statute 458.351 standard. The cost of that mistake is not the creative rework — it is the board complaint, the licensure defence, and the reputational surface area that follows.
HIPAA, TCPA, CAN-SPAM, ADA, FTC, FDA — the federal envelope every US plastic surgery campaign runs inside
Alongside the state medical board and the ABPS/ASPS/Aesthetic Society overlay sits a federal envelope that applies uniformly across all 50 states. A US plastic surgery marketing plan that does not scope against every framework below is not a plan — it is an exposure profile the practice will carry until its first regulator complaint.
HIPAA (OCR 2022/2024 tracking bulletin)
Condition, procedure or provider information passed to a third-party analytics or ad platform can constitute PHI when tied to an individual identifier. Every plastic surgery engagement starts with a PHI scrub across GA4, Google Ads conversions, Meta CAPI, TikTok Events API, Clarity, Hotjar, LiveChat and every third-party embed on the practice website. BAA-ready with every partner that requires one.
TCPA (2024 FCC revocation updates)
$500 to $1,500 statutory damages per violating message. Every lead-form disclosure, pre-op reminder SMS, financing follow-up SMS, post-op recovery drip, and revision-consult outreach is audited against the current TCPA rule set including the 2024 revocation-of-consent updates.
CAN-SPAM Act
Every US plastic surgery email marketing program — event invites, seasonal specials, financing partner co-marketing, revision education — is scoped for accurate sender identification, honest subject lines, physical postal address disclosure, and functioning one-click unsubscribe.
ADA (web accessibility)
Plastic surgery websites are Title III places of public accommodation. WCAG 2.1 AA is the operative accessibility floor. We audit new-build and legacy plastic surgery websites against WCAG 2.1 AA (contrast, alt text, keyboard navigation, ARIA labelling) as part of engagement onboarding.
FTC 16 CFR §255 (Endorsement Guides)
Any influencer collaboration, patient advocate story, or incentivised Google/RealSelf review triggers the FTC Endorsement Guides. Material connection disclosure, honest depiction of results, and truthful representation of the endorser's actual experience are all in scope. We do not run influencer or review-incentive programs without an FTC-compliant disclosure structure built in. Financing partner co-marketing is scoped for FTC truth-in-lending compliance.
FDA 21 CFR §202.1 (device and prescription advertising)
Any promotional communication that mentions specific implant brands, energy-based device brands, or prescription pain and anti-nausea management is subject to FDA advertising rules. Fair balance, indication accuracy, and risk information disclosure are scoped into every relevant creative asset before publication.
Meta Personal Attributes policy
Meta's ad-review system rejects creative that implies knowledge of a person's body, appearance, weight, medical condition or health status. Plastic surgery creative that reads clean to a human reviewer can trigger a Personal Attributes rejection at scale. We rewrite creative pre-flight against the current Meta policy interpretation and monitor account-level policy risk continuously.
Google Healthcare policy + before/after ad restrictions
Google Ads applies personalisation restrictions on health-related audiences and has tightened restrictions on before/after imagery in ads for cosmetic procedures. Every US plastic surgery Google Ads engagement is set up under the correct policy classification from account creation, with creative built to comply within the current before/after image posture.
What the monthly stack actually delivers for a US plastic surgery practice
Every plastic surgery engagement runs on the same six delivery layers, weighted per practice. A solo ABPS-certified surgeon in Beverly Hills weights heavier on paid social, RealSelf and Instagram case galleries; a multi-surgeon plastic surgery group in Texas weights heavier on surgeon-provider content and GBP density; a PE-backed multi-state cosmetic surgery platform weights heavier on per-location P&L attribution and financing partner co-marketing across states.
1. SEO — procedure catalogue + surgeon-authority clusters
Two separate topic maps: procedure catalogue (breast, body, face, gender-affirmation, revision) with each procedure carrying its own indication, technique, recovery, cost and financing content; surgeon-authority cluster built around each ABPS-certified surgeon as the individual trust anchor. Site architecture routes buyer research from procedure interest into surgeon comparison in the same session.
2. Paid — Google + Meta with tight before/after compliance
Google Ads on branded and non-branded procedure intent, geo-fenced to ZIP-code catchments each surgeon actually sees patients from. Meta Advantage+ campaigns with HIPAA-scoped audience construction, TCPA-safe lead-form consent language, and Personal Attributes-compliant creative library. All before/after imagery scoped for Google Healthcare policy and Meta ad-review compliance.
3. GBP density — per location, per state
Angryturtle-run GBP for every clinical address, category-optimised for plastic surgery with procedure-specific service listings. Post cadence, review response, Q&A seeding, procedure gallery hygiene — all scoped to state medical board testimonial rules and ABPS/ASPS advertising standards.
4. YouTube surgeon-authority (YODA)
Long-form surgeon-authority publishing that positions each ABPS-certified surgeon as the citation surface for AI Overviews and PAA panels on plastic surgery queries. Procedure explainers, technique walkthroughs, recovery guides, and revision case discussion with ABPS/ASPS-compliant framing. Doubles as the pre-consult education library.
5. Reputation cross-monitoring including RealSelf
Google, RealSelf, Healthgrades, Vitals, Zocdoc, Reddit plastic surgery subreddits. RealSelf reviewer profile depth is one of the largest single conversion factors in plastic surgery consult booking; the reputation strategy has to invest there specifically. Review-request cadence tied to satisfied-patient triggers with state-consent capture.
6. Financing partner integration + CRM attribution
CareCredit, Alphaeon, PatientFi and Cherry pre-consult financing check pages, in-consult application handoff, post-consult financing follow-up drips — built into the acquisition engagement. CRM integration where the practice runs one; call-tracking with HIPAA-scoped recording where they do not. Per-location, per-surgeon, per-procedure P&L attribution back to signed operative cases, not just to consult clicks.
The US plastic surgery buyer journey — six to eighteen months of research to one operative case
US plastic surgery buyers move through the longest and most-researched buyer journey in cash-pay medicine. Understanding the specific shape of the journey — and where marketing changes the outcome — is what separates a plan that fills the operative schedule from one that just accumulates consult form fills that never convert to booked cases.
Stage 1 — Interest formation
Plastic surgery interest forms slowly. A trigger event (post-baby body change, GLP-1 weight loss revealing loose skin, aging change the buyer decides to address, a peer's outcome that reset the reference point) begins a research window that typically runs six to eighteen months for elective aesthetic surgery. The buyer's initial research is often generic — "tummy tuck cost", "breast augmentation recovery", "rhinoplasty types" — before they narrow to specific surgeons in their metro. Marketing has to be findable on the whole procedure-education topic set, not just on surgeon-name queries.
Stage 2 — Surgeon shortlisting
This stage is where plastic surgery marketing wins or loses the case. Buyers narrow to a shortlist of two to five surgeons based on board certification verification, RealSelf reviewer depth, before/after case gallery breadth, YouTube education presence, and referral input from friends or physicians. Board certification verification is critical — buyers cross-check the surgeon's ABPS diplomate status against fake board claims that have proliferated across the internet. The surgeon-authority content library is what pulls the surgeon into the shortlist.
Stage 3 — Consult booking
Plastic surgery consults skew heavily phone-call-led rather than online-book-led. A buyer investing six months of research and $10,000 to $60,000 wants a phone conversation before committing to a paid consult ($150 to $500 typical consult fee, often applied to the case if the buyer books). We build phone-first flows with a call-tracking overlay that captures every consult inquiry, HIPAA-scoped recording where BAA-covered, and back-office consult-scheduling workflows that reduce booking friction without losing the phone-conversation trust anchor.
Stage 4 — Consult and financing decision
The consult itself is where the case converts — or does not. Financing is decided in the consult-to-book window (typical 3 to 21 days between consult and paid deposit for booked cases). Marketing extends into this window through post-consult financing follow-up SMS, personalised procedure-plan email drips, and financing partner (CareCredit, Alphaeon, PatientFi, Cherry) pre-approval nudges. Practices that treat the post-consult window as marketing-inactive lose material book-rate they could have kept.
Stage 5 — Pre-op, operative and post-op
Once the case is booked, the marketing motion shifts to patient education and pre-op prep — HIPAA and TCPA-scoped SMS reminders, post-op recovery drips, revision policy education, and cross-sell into complementary aesthetic services (skin regimens, non-surgical face treatments, injectable maintenance). The plastic surgery LTV runs 1.4× to 3× the primary case value when the practice's post-op journey is properly designed. We scope this into the acquisition engagement.
Stage 6 — Referral and revision
Mature plastic surgery practices generate 40 to 60 percent of new consults through patient referral. The referral engine is built into the post-op journey: post-op consent-based photo capture (with state consent rules honoured), post-op survey trigger for review request timing, referral-friendly touchpoint design. Revision consult intake (both revision of the surgeon's own cases and outside-revision cases) is a distinct funnel we build alongside primary consult acquisition.
What a US plastic surgery engagement costs — and consult CPQL to expect per metro
Retainers are custom-scoped per practice against surgeon count, location count, state footprint, procedure catalogue mix, financing partner integration depth, and desired share of the metro market. There are no packaged tiers because a solo ABPS-certified surgeon in Beverly Hills does not need the same stack as a multi-state cosmetic surgery platform.
Practical retainer ranges by practice profile:
- Solo ABPS-certified plastic surgeon, one high-CPC metro location — $2,500 to $4,500/month. SEO + GBP + one paid channel (usually Google on procedure intent), monthly reporting, quarterly surgeon-authority content review.
- Two-to-four surgeon plastic surgery group, single state — $4,500 to $6,500/month. Full SEO stack across procedure catalogue and surgeon clusters, GBP density per location, Google + Meta paid, reputation cross-monitoring including RealSelf, YouTube surgeon-authority pilot, financing partner integration.
- Multi-state cosmetic surgery group or PE-backed platform — $6,500 to $8,000+/month. Full stack plus per-location, per-state P&L attribution, per-surgeon content publishing, national SEO across every state, CRM integration for true cost-per-signed-operative-case reporting, and cross-state financing partner co-marketing.
Media spend runs pass-through and is scoped separately, typically $5,000 to $60,000 per month depending on ambition and the number of markets in play. Product SKUs like Angryturtle ($12/month per location for GBP OS) run in parallel where per-location density is the acquisition constraint.
National CPQL benchmarks — cost per plastic surgery consult by metro cohort
Plastic surgery CPQL is priced against a paid, showed-up, in-office consult with the ABPS-certified surgeon — not against a top-of-funnel form fill. The ranges below are mature-campaign benchmarks Ichelon Global operates against across our current US book, not first-90-day exploration numbers.
- Top-CPC metros (Miami, Beverly Hills, Manhattan, Dallas). Body procedure consults (BBL, tummy tuck, mommy makeover) typically return $250 to $500 per consult. Face procedure consults (rhinoplasty, facelift, deep-plane facelift, blepharoplasty) $300 to $500. Breast procedure consults $180 to $380.
- Mid-CPC metros (Houston, Atlanta, Nashville, Austin, Chicago, Boston, San Diego). Body procedure consults $180 to $340. Face procedure consults $200 to $360. Breast procedure consults $120 to $260.
- Emerging metros (Charlotte, Raleigh, Denver, Portland, San Antonio, Kansas City, Minneapolis). Body procedure consults $130 to $250. Face procedure consults $150 to $280. Breast procedure consults $95 to $200.
- Revision consults. Revision intake — both revision of the surgeon's own cases and outside-revision case intake — is a separate funnel. CPQL typically runs 1.4× to 2× the primary consult band in the same metro because buyer research is more anxious and shortlist windows are shorter.
The important number is not consult CPQL alone — it is cost-per-signed-operative-case. Consult-to-book conversion typically runs 30 to 55 percent in mature accounts depending on procedure category and financing integration depth. A consult CPQL of $300 on a 45 percent book rate is a $667 cost-per-signed case, which on a $20,000 average ticket is a marketing spend of 3.3 percent of case revenue — the target band for a well-run plastic surgery practice.
City-level plastic surgery pages Ichelon Global maintains — the national cluster
This flagship page consolidates the semantic cluster of city-level plastic surgery marketing pages Ichelon Global maintains across the US. Each metro page below carries its own state medical board scoping, its own paid-media CPC calibration, and its own submarket-level demand data. Practices researching us should read the metro page for their own market alongside this national flagship.
Not listed above? We take on new-market engagements every quarter. If your plastic surgery practice operates in a metro that does not have a dedicated Ichelon Global page yet — Chicago, Boston, Seattle, Denver, Minneapolis, San Diego, Philadelphia, Charlotte, Portland, Salt Lake City and dozens more are actively serviced without a dedicated landing page yet — the delivery stack and pricing are identical.
Search Intelligence Trifecta — organic and paid on one national stack
Every US plastic surgery engagement runs on the Search Intelligence Trifecta — Angryturtle, SIE and YODA. Paid acquisition buys the consult today; SIE earns the ranking tomorrow so the same query is free next quarter. YODA builds the surgeon-authority library that pulls in both primary and revision consult intent. Angryturtle keeps every US clinical address dense on Google Maps.
Angryturtle · GBP OS for every US location
Post cadence, review response, Q&A seeding, procedure gallery hygiene, service catalogue depth — scoped to each state's testimonial rules and ABPS/ASPS advertising standards. Multi-surgeon groups get consolidated review monitoring across every clinical address. Solo plan from $12/month per location; agency-managed plans priced separately.
SIE · Search Intelligence Engine
Topic map, entity graph and internal-link engineering around US plastic surgery query patterns — procedure-catalogue level, surgeon-provider level, financing-partner-integrated URL structures. Content briefs optimised for AI Overview citation and PAA answer boxes on plastic surgery intent across state, metro and neighbourhood queries.
YODA · YouTube AIO for plastic surgery
Surgeon-authority builds — procedure explainers, technique walkthroughs, recovery-timeline education, revision case discussion with ABPS/ASPS-compliant framing. Optimised for AI Overview citation and YouTube's recommendation engine. Doubles as the pre-consult education library and revision intake pull.
US plastic surgery marketing — national-scope questions
How does Ichelon Global handle the ABPS/ASPS/Aesthetic Society advertising overlay for national plastic surgery practices?
Every campaign asset — website copy, GBP posts, ads, YouTube titles, RealSelf profile language, financing partner co-marketing — is scoped against ABPS board certification standards, ASPS Code of Ethics advertising provisions, and where the practice is a member, The Aesthetic Society advertising guidance. We systematically remove language that implies board certification the surgeon does not actually hold, hedge outcome language to match ASPS realistic-depiction standards, and update BBL-related creative to reflect post-2022 multi-society safety framing.
What is the CPQL range for plastic surgery consults across US metros?
Body procedure consults (BBL, tummy tuck, mommy makeover) run $130 to $250 in emerging metros, $180 to $340 in mid-CPC metros (Houston, Atlanta, Nashville, Austin), and $250 to $500 in top-CPC metros (Miami, Beverly Hills, Manhattan, Dallas). Face procedure consults sit slightly higher within each band; breast procedure consults sit slightly lower. Revision consults run 1.4× to 2× the primary consult band.
Do you integrate CareCredit, Alphaeon, PatientFi and Cherry into the acquisition engagement?
Yes. Financing partner integration is one of the highest-ROI additions to a plastic surgery marketing engagement. We build pre-consult financing eligibility check landing pages, in-consult application handoff workflows, and post-consult financing follow-up drips across CareCredit, Alphaeon, PatientFi and Cherry. Practices that integrate financing pre-consult and inside the consult typically convert 15 to 30 percent more consults to signed cases compared to treating financing as a payment-desk afterthought.
How do you handle BBL creative post-2022 safety framing?
We scope every BBL creative and content piece against the current multi-society safety guidance — subfascial technique framing, ultrasound guidance disclosure where the surgeon uses it, appropriate patient selection language, and honest mortality-risk education where the practice's counsel supports including it. Marketing that ignores post-2022 BBL safety language is a discovery liability in medico-legal defence; scoped correctly, it becomes a trust differentiator against competitors still running pre-2022 language.
How does the RealSelf, Reddit and Instagram reputation surface work for plastic surgery?
RealSelf is the single most important reputation surface in plastic surgery. Buyer research routes heavily through RealSelf reviewer profile depth, and the platform's Q&A activity is a distinct trust surface most practices under-invest in. Reddit plastic surgery subreddits carry disproportionate weight on procedure-specific research and are a live source of revision consult intent. Instagram case galleries anchor visual trust. We build the reputation strategy around all four surfaces (Google + RealSelf + Reddit + Instagram) rather than only Google.
Do you serve US plastic surgery practices outside Texas, California, Florida and New York?
Yes. We currently run engagements across Georgia, Arizona, Tennessee, Illinois, Washington, Colorado, North Carolina, Massachusetts and other states, and we scope net-new engagements in any state where an ABPS/ASPS-certified plastic surgeon can advertise. Not having a dedicated metro landing page for a market does not mean we do not serve it.
How do you handle Meta Ads Personal Attributes rejections on plastic surgery creative?
Plastic surgery is one of the highest-risk categories for Meta Personal Attributes rejection because the creative can be read to imply knowledge of a person's body, appearance or weight. We rewrite creative pre-flight against the current Meta policy interpretation, monitor account-level policy risk continuously, and structure campaigns to reduce the surface area for cascading account restrictions. Rejections are appealed through official Meta channels rather than resubmitted under a different account.
How does the Dallas HQ work for a plastic surgery practice on the other side of the country?
Dallas is where our US delivery pod sits — leadership, senior strategy, creative direction and reporting. Central time zone gives us working overlap with every US metro. Client calls happen on Google Meet or Zoom; reporting is asynchronous and on-demand; senior team travel to on-site strategy sessions is scoped where the engagement warrants it. Practices in California, Florida, New York and every other state we serve get the same senior attention as practices in DFW itself — the physical office is the compliance and delivery anchor, not a limitation on client geography.
Scope your US plastic surgery marketing engagement
Book a 30-minute scoping call with a member of the Leadership Team, email Santosh (Dallas HQ) directly, or WhatsApp us. Central time zone hours, same day where we can.
Adjacent US aesthetic and cosmetic pillar pages
Healthcare brands ICG
has worked with.
A representative slice of the 300+ healthcare brands ICG has delivered for across India. Full client list available under NDA during a Brand and Growth Diagnostic.
